New AIDS vaccine ready for trials
July 1st, 2009 - 2:04 pm ICT by IANSToronto, July 1 (IANS) The Canadian University of Western Ontario has developed a new HIV/AIDS vaccine that is ready for human trials.
The vaccine called SAV001H has been developed by the university at London, about 160 km from here, in collaboration with Sumagen Canada, a subsidiary of the Korean pharmaceutical company.
In a statement Tuesday, Sumagen Canada said it has submitted an application to the US Food and Drug Administration (FDA) to begin the first phase of trials of the vaccine on human beings.
Chil-Yong Kang, a professor at the university, said they have completed safety and immunogenicity studies of the vaccine on animals. Immunogenicity measures the ability of a drug or vaccine to provoke an immune response in the body.
Trials of the new vaccine on animals have reportedly resulted in good anti-body reactions with no adverse effects.
Numerous trials have been carried out by pharmaceutical companies to develop vaccines since the AIDS virus was recognized in 1983, but no commercialised vaccine has been developed so far.
Sumagen Canada has secured patents for the vaccine in over 70 countries, including the US, the European Union and Korea.
It said the phase one clinical trials of the vaccine will double check its safety on HIV positive volunteers. The phase two trials would assess the immunogenicity of the vaccine.
Sumagen Canada said it is ready for clinical trials in the US as soon the FDA approval is granted.
The University of Western Ontario and the city of London have been short-listed by the Canadian government to set up an $88 million HIV vaccine manufacturing facility, which will be partly funded by the Bill and Melinda Gates Foundation.
Just last week Canadian scientists had announced a major breakthrough in AIDS treatment by saying that they have found where the HIV virus hides in the human body.
Currently, AIDS patients have to take a cocktail of up to five to six drugs to prolong their life up to 13 years.
There are over 33 million HIV patients worldwide, with 2.7 million more getting infected each year.
- Chinese scientists a step closer to creating HIV vaccine - Apr 04, 2011
- First vaccine against kala azar ready for trial - Feb 22, 2012
- Cuba to test new AIDS vaccine - Mar 07, 2012
- US approves new HIV treatment - May 21, 2011
- First ever pill to beat HIV under FDA consideration - May 10, 2012
- Monkey jab may open way for HIV vaccine - May 12, 2011
- Human trials under way for new HIV vaccine - Jan 03, 2012
- HIV vaccine being tested in Spain - Sep 29, 2011
- Promising new HIV drug keeps virus out of cells - Aug 19, 2010
- Chinese drug passes US clinical trials for first time - Aug 07, 2010
- Symposium shows progress in TB vaccines - Jun 08, 2010
- Scientist unravels how HIV hijacks body defences - Jan 01, 2012
- FDA-approved drugs that may fight HIV identified - Aug 21, 2010
- New tuberculosis (TB) Vaccine could be ready by 2020 - Jul 19, 2010
- Russia tests HIV vaccine - Feb 06, 2012
Tags: aids treatment, aids virus, bill and melinda gates, bill and melinda gates foundation, canadian scientists, city of london, fda approval, food and drug administration, food and drug administration fda, hiv aids, hiv vaccine, hiv virus, immune response, immunogenicity, melinda gates foundation, new aids vaccine, university of western ontario, us food and drug administration, virus hides, yong kang